ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Driving restrictions in patients with ICD and pacemaker in four countries/regions

Driving restrictions in patients with ICD and pacemaker in four countries/regions
  License type Japan UK USA EU
Pacemaker implant Class 1 Cease driving for 1 week. Cease driving for 1 week. Cease driving for 1 week. Cease driving for 1 week.
Class 2 Disqualified until pacemaker integrity is ascertained. Cease driving for 6 weeks. Cease driving for 4 weeks. Disqualified if persistent symptoms.
ICD implant for VT/VF with incapacity (secondary prevention) Class 1 Cease for 6 months after first implant. Cease for 6 months after first implant. Cease for 6 months after first implant. Cease for 3 months.
Class 2 Permanently bars. Permanently bars. Permanently bars. Permanently bars.
ICD implant for sustained VT without incapacity (secondary prevention) Class 1 Cease for 6 months after first implant. Cease for 1 month after first implant provided all of the following are met:
  1. LVEF >35%.
  2. No fast VT on EPS.
  3. Any induced VT could be pace-terminated by the ICD twice, without acceleration, during the post-implantation study.
Cease for 6 months after implant. Cease for 3 months after implant.
Class 2 Permanently bars. Permanently bars. Permanently bars. Permanently bars.
Prophylactic ICD implantation (primary prevention) Class 1 Cease for 1 week. Cease for 1 month. Cease for 1 week. Cease For 4 weeks.
Class 2 Permanently bars. Permanently bars. Permanently bars. Permanently bars.
ICD and lead system replacement Class 1 Cease For 1 week after replacement of the lead system or replacement of the ICD. Cease for 1 month after a revision of the leads or antiarrhythmic drug change. No specific guidance.

Cease For 4 weeks after replacement of the ICD and lead system or the lead system alone.

Cease For 1 week after replacement of ICD.
Delivery of ICD therapy Class 1

Cease for 3 months after appropriate therapy.

Inappropriate therapy: no restrictions for asymptomatic episodes. Cease for 3 months in case of syncope.

Appropriate shock plus symptomatic ATP: Cease for 6 months with corrective measures to prevent recurrence provided no further symptomatic therapy.

Inappropriate therapy: cease for 1 month after the cause of the inappropriate therapy was corrected.

Cease for 6 months after appropriate therapy.

Inappropriate therapy: no distinction made from appropriate therapy.

Cease for 3 months after appropriate therapy.

Inappropriate therapy: cease until cause of inappropriate therapy was corrected.
Driving restrictions in various countries/regions. A class 1 license is a license to operate one's own vehicle for personal use, while a class 2 license is a commercial license for those who drive a vehicle for work.
ICD: implantable cardioverter-defibrillator; VT: ventricular fibrillation; VF: ventricular fibrillation; LVEF: left ventricular ejection fraction; EPS: electrophysiologic test; ATP: antitachycardia pacing.
Reproduced from: Watanabe E, Abe H, Watanabe S. Driving restrictions in patients with implantable cardioverter defibrillators and pacemakers. J Arrhythm 2017; 33:594. Table used with the permission of Elsevier, Inc. All rights reserved.
Graphic 120456 Version 1.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟